Transgenic Operative Products Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.42M
Latest Deal Amount
  • Investors
  • 1

Transgenic Operative Products General Information

Description

Developer of a drug discovery technology intended to assist in the detection of toxic compounds in food products. The company's technology specializes in the generation of vectors and cells for research with optic imaging that aids in detecting toxic chemical compounds in the environment and food products, enabling clients to have the visualization of molecular events in real time and in all the organs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Via Einstein
  • Località Cascina Codazza
  • 26900 Lodi
  • Italy
+39 0371 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transgenic Operative Products Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 25-Oct-2007 $1.42M 00.000 Completed Generating Revenue
To view Transgenic Operative Products’s complete valuation and funding history, request access »

Transgenic Operative Products Executive Team (2)

Name Title Board Seat Contact Info
Adriana Maggi Co-Founder, Board Member & President
Paolo Ciana Ph.D Co-Founder, Board Member & Vice President
To view Transgenic Operative Products’s complete executive team members history, request access »

Transgenic Operative Products Board Members (3)

Name Representing Role Since
Carlo Rosa Self Board Member 000 0000
Dario Casati Self Board Member 000 0000
To view Transgenic Operative Products’s complete board members history, request access »

Transgenic Operative Products Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finlombarda Gestioni Venture Capital Minority 000 0000 000000 0
To view Transgenic Operative Products’s complete investors history, request access »